FIELD: medicine; pharmaceutics.
SUBSTANCE: dry powder inhalation composition containing at least one API and a lipid matrix containing at least one triglyceride, selected from a group consisting of monohydroxystearin, dihydroxystearin, trihydroxystearin and a mixture thereof, and a method for preparing it.
EFFECT: dry powder inhalation composition and its use for pulmonary drug treatment are proposed.
23 cl, 9 dwg, 31 ex
Title | Year | Author | Number |
---|---|---|---|
CATIONS OF MONOVALENT METALS OF DRY POWDERS FOR INHALATIONS | 2011 |
|
RU2640921C2 |
DIRECTED DELIVERY OF SPRAY-DRIED COMPOSITIONS INTO THE LUNGS | 2016 |
|
RU2731212C2 |
ANTIFUNGAL DRY POWDERS | 2017 |
|
RU2766086C2 |
DEAMORPHIZATION OF SPRAY-DRIED FORMULATIONS VIA SPRAY-BLENDING | 2014 |
|
RU2698331C2 |
DRY POWDER COMPOSITIONS REPRESENTED AS PARTICLES WHICH CONTAIN TWO OR MORE ACTIVE INGREDIENTS FOR TREATMENT OF OBSTRUCTIVE OR INFLAMMATORY DISEASES OF RESPIRATORY WAYS | 2012 |
|
RU2629333C2 |
DRY POWDER FORMULATIONS AND METHODS OF TREATING PULMONARY DISEASES | 2010 |
|
RU2577698C2 |
STABLE NON-AQUEOUS PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2472492C2 |
FILLER FOR CAPSULAR INHALER | 2016 |
|
RU2634258C1 |
METHODS OF TREATING FUNGAL INFECTIONS | 2019 |
|
RU2820457C2 |
DIKETOPIPERAZIN MICROPARTICLES WITH PARTICULAR AMOUNT OF ISOMERS | 2010 |
|
RU2490026C1 |
Authors
Dates
2024-04-11—Published
2019-12-27—Filed